Healthcare & Life Sciences Industry Updates

Google News – FDA (biotech/pharma) External News

Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemia - BioSpace

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

CureMetrix gains FDA clearance for next-generation BAC detection and quantification - Scientist Live

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers - PharmTech.com

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

J&J MedTech nabs Monarch Quest update for lung cancer detection - Fierce Biotech

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

Aurobindo North Carolina facility secures establishment report from FDA - pharma.economictimes.indiatimes.com

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

OncoSil secures FDA approval for targeted bile duct cancer device - BiotechDispatch

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

EIT Pharma Announces FDA Acceptance of New Drug Application for Lonafarnib for Treatment of Chronic Hepatitis D - BioSpace

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

Pharmalittle: We're reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more - STAT

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

Aptar Pharma Announces Progress on Multi-Year U.S. FDA-Funded Research Contract - Aptar

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA Begins Pilot To Incentivize US-Based Pharma Manufacturing - DCAT Value Chain Insights

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

The FDA was all in on AI. Will that change? - pharmavoice.com

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca - Fierce Pharma

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

Viridian, awaiting FDA decision, taps WuXi Bio in supply deal - Fierce Pharma

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA returns to releasing pharma rejection letters with 14 new CRLs - endpoints.news

news.google.com · 19 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA vaccines chief who ran afoul of pharma to depart - Politico

news.google.com · 19 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device

Trump nominates policy aide Overton to lead FDA

FDA seeks feedback on generative AI regulations

GE HealthCare names new CFO

Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemia - BioSpace

CureMetrix gains FDA clearance for next-generation BAC detection and quantification - Scientist Live

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers - PharmTech.com

J&J MedTech nabs Monarch Quest update for lung cancer detection - Fierce Biotech

Aurobindo North Carolina facility secures establishment report from FDA - pharma.economictimes.indiatimes.com

OncoSil secures FDA approval for targeted bile duct cancer device - BiotechDispatch

EIT Pharma Announces FDA Acceptance of New Drug Application for Lonafarnib for Treatment of Chronic Hepatitis D - BioSpace

Pharmalittle: We're reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more - STAT

Aptar Pharma Announces Progress on Multi-Year U.S. FDA-Funded Research Contract - Aptar

FDA Begins Pilot To Incentivize US-Based Pharma Manufacturing - DCAT Value Chain Insights

The FDA was all in on AI. Will that change? - pharmavoice.com

Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca - Fierce Pharma

Viridian, awaiting FDA decision, taps WuXi Bio in supply deal - Fierce Pharma

FDA returns to releasing pharma rejection letters with 14 new CRLs - endpoints.news

FDA vaccines chief who ran afoul of pharma to depart - Politico